Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Application of Förster Resonance Energy Transfer (FRET) technique to elucidate intracellular and In Vivo biofate of nanomedicines.

Chen T, He B, Tao J, He Y, Deng H, Wang X, Zheng Y.

Adv Drug Deliv Rev. 2019 Jun 12. pii: S0169-409X(19)30064-X. doi: 10.1016/j.addr.2019.04.009. [Epub ahead of print]

PMID:
31201837
2.

What nanomedicine in the clinic right now really forms nanoparticles?

Svenson S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Mar-Apr;6(2):125-35. doi: 10.1002/wnan.1257. Epub 2014 Jan 10.

PMID:
24415653
3.

Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.

Gupta M, Agrawal GP, Vyas SP.

Curr Mol Med. 2013 Jan;13(1):179-204. Review.

PMID:
22834834
4.

[Regulatory science researches of nanomedicines].

Sakai-Kato K, Goda Y.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2014;(132):3-5. Japanese.

PMID:
25707194
5.

Fluorescence Resonance Energy Transfer Visualization of Molecular Delivery from Polymeric Micelles.

Liang Y, Huo Q, Lu W, Jiang L, Gao W, Xu L, Han S, Cao J, Zhang T, Sun Y, He B.

J Biomed Nanotechnol. 2018 Jul 1;14(7):1308-1316. doi: 10.1166/jbn.2018.2585.

PMID:
29944104
6.

Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA.

Prog Retin Eye Res. 2013 Sep;36:172-98. doi: 10.1016/j.preteyeres.2013.04.001. Epub 2013 Apr 17. Review.

7.

Quantum dots, lighting up the research and development of nanomedicine.

Wang Y, Chen L.

Nanomedicine. 2011 Aug;7(4):385-402. doi: 10.1016/j.nano.2010.12.006. Epub 2011 Jan 5. Review.

PMID:
21215327
8.

Artificial chaperones based on mixed shell polymeric micelles: insight into the mechanism of the interaction of the chaperone with substrate proteins using Förster resonance energy transfer.

Wang J, Yin T, Huang F, Song Y, An Y, Zhang Z, Shi L.

ACS Appl Mater Interfaces. 2015 May 20;7(19):10238-49. doi: 10.1021/acsami.5b00684. Epub 2015 May 11.

PMID:
25939050
9.

Computational studies of micellar and nanoparticle nanomedicines.

Sen S, Han Y, Rehak P, Vuković L, Král P.

Chem Soc Rev. 2018 Jun 5;47(11):3849-3860. doi: 10.1039/c8cs00022k. Review.

PMID:
29645040
10.

Safety and Toxicological Considerations of Nanomedicines: The Future Directions.

Patel P, Shah J.

Curr Clin Pharmacol. 2017;12(2):73-82. doi: 10.2174/1574884712666170509161252. Review.

PMID:
28486906
11.

Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.

Lainé AL, Gravier J, Henry M, Sancey L, Béjaud J, Pancani E, Wiber M, Texier I, Coll JL, Benoit JP, Passirani C.

J Control Release. 2014 Aug 28;188:1-8. doi: 10.1016/j.jconrel.2014.05.042. Epub 2014 May 28.

PMID:
24878182
12.

Investigating supramolecular systems using Förster resonance energy transfer.

Teunissen AJP, Pérez-Medina C, Meijerink A, Mulder WJM.

Chem Soc Rev. 2018 Sep 17;47(18):7027-7044. doi: 10.1039/c8cs00278a. Review.

PMID:
30091770
13.

Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy.

Huang P, Song H, Zhang Y, Liu J, Zhang J, Wang W, Liu J, Li C, Kong D.

ACS Appl Mater Interfaces. 2016 Nov 2;8(43):29323-29333. Epub 2016 Oct 19.

PMID:
27731617
14.

Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging.

Chen H, Kim S, Li L, Wang S, Park K, Cheng JX.

Proc Natl Acad Sci U S A. 2008 May 6;105(18):6596-601. doi: 10.1073/pnas.0707046105. Epub 2008 Apr 29.

15.

Nanomedicines as cancer therapeutics: current status.

Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ.

Curr Cancer Drug Targets. 2013 May;13(4):362-78. Review.

PMID:
23517593
16.

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

Muthu MS, Singh S.

Nanomedicine (Lond). 2009 Jan;4(1):105-18. doi: 10.2217/17435889.4.1.105.

PMID:
19093899
17.

Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.

Kwon S, Ko H, You DG, Kataoka K, Park JH.

Acc Chem Res. 2019 Jul 16;52(7):1771-1782. doi: 10.1021/acs.accounts.9b00136. Epub 2019 Jun 26.

PMID:
31241894
18.

In vitro and in vivo assessment of delivery of hydrophobic molecules and plasmid DNAs with PEO-PPO-PEO polymeric micelles on cornea.

Hsiao F, Huang PY, Aoyagi T, Chang SF, Liaw J.

J Food Drug Anal. 2018 Apr;26(2):869-878. doi: 10.1016/j.jfda.2017.09.002. Epub 2017 Nov 10.

19.

Polymeric mixed micelles as nanomedicines: Achievements and perspectives.

Cagel M, Tesan FC, Bernabeu E, Salgueiro MJ, Zubillaga MB, Moretton MA, Chiappetta DA.

Eur J Pharm Biopharm. 2017 Apr;113:211-228. doi: 10.1016/j.ejpb.2016.12.019. Epub 2017 Jan 11. Review.

PMID:
28087380
20.

FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.

Gravier J, Sancey L, Hirsjärvi S, Rustique E, Passirani C, Benoît JP, Coll JL, Texier I.

Mol Pharm. 2014 Sep 2;11(9):3133-44. doi: 10.1021/mp500329z. Epub 2014 Aug 13.

PMID:
25098740

Supplemental Content

Support Center